Nicox Stock Forecast for 2023 - 2025 - 2030
Updated on 05/03/2024
Nicox Stock Forecast and Price Target
Nicox's stock price reaches the average target of 1.00€ by 2025 as expected recently by notable experts, there would be a potential upside of approximately 156.41% from the last closing price in May, 2024. This possible increase is based on a high estimate of 1.00€ and a low estimate of 1.00€. If you're considering investing in ALCOX stock, it's important to look at its competitors too.
156.41% Upside
Nicox Fair Value Forecast for 2023 - 2025 - 2030
Nicox's Price has seen growth In the last four years, going from 0.00€ to 0.00€ – a gain of 100.00% In the next year, analysts believe that Fair Value will reach 0.41€ – an increase of 100.00%. For the next seven years, the forecast is forFair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SAN Stock Forecast | Sanofi | Outperform |
16
|
91.90€ | Buy/Sell | 102.80€ | 18.61% |
| IPN Stock Forecast | Ipsen | Hold |
17
|
115.10€ | Buy/Sell | 127.95€ | 4.26% |
| VETO Stock Forecast | Vetoquinol | Hold |
18
|
95.60€ | Buy/Sell | 106.50€ | 12.97% |
| BOI Stock Forecast | Boiron | Outperform |
16
|
34.05€ | Buy/Sell | 43.93€ | 16.30% |
| MEDCL Stock Forecast | MedinCell | Buy |
7
|
14.36€ | Buy/Sell | 16.68€ | 6.55% |
Nicox Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Nicox's Revenue has fallen from 12.91€M to 3.27€M – a 74.67% decrease. In the next year, analysts believe that Revenue will reach 5.80€M – an increase of 77.37%. For the next seven years, the forecast is forRevenue to grow by 162.76%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ALSEN Stock Forecast | Sensorion | Buy |
6
|
0.70€ | Buy/Sell | 2.33€ | 257.14% |
| AB Stock Forecast | AB Science | Buy |
6
|
1.90€ | Buy/Sell | 10.00€ | 263.16% |
| MLOLM Stock Forecast | Olmix Société Anonyme | - |
0
|
0.00€ | Buy/Sell | 0.00€ | 0.00% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ALVAL Stock Forecast | Valbiotis | Buy |
0
|
4.11€ | Buy/Sell | 10.07€ | 123.84% |
| ALMDP Stock Forecast | Medesis Pharma | - |
0
|
0.81€ | Buy/Sell | 0.00€ | -100.00% |
| ALDVI Stock Forecast | Advicenne | Buy |
6
|
1.63€ | Buy/Sell | 6.90€ | 323.31% |
Nicox EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Nicox's EBITDA has increased by 314.53%, going from -5.16€M to -21.39€M. In the next year, 1 analysts estimate that Nicox's EBITDA will decrease by 10.75%, reaching -19.09€M. According to professional forecasts, in 2030, Nicox's EBITDA will decrease by 24.09%, reaching -16.24€M.
Nicox EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Nicox's EBIT has grown, increasing from -6.90€M to -21.73€M – an increase of 214.93%. According to 2 analysts, Nicox's EBIT will fall by 20.80% in the next year, reaching -17.21€M. Professionals believe that By 2030, Nicox's EBIT will fall to -16.24€M – a 25.26% decrease from its current value.
Nicox EPS Price Prediction Forecast for 2023 - 2025 - 2030
Nicox's EPS has seen growth In the last four years, going from -0.54€ to 0.00€ – a gain of 100.00% In the next year, analysts believe that EPS will reach -0.37€ – an increase of 100.00%. For the next seven years, the forecast is forEPS to grow by 100.00%.
.jpg)